Immune checkpoint inhibitors (ICIs) have revolutionized our approach to cancer treatment in
the past decade. While monoclonal antibodies to CTLA‐4 and PD‐1/PD‐L1 have produced …

Sarcomas are complex mesenchymal neoplasms with a poor prognosis. Their clinical
management is highly challenging due to their heterogeneity and insensitivity to current …

Importance Alveolar soft-part sarcoma (ASPS) is a rare, translocation-driven sarcoma of the
soft tissues. Alveolar soft-part sarcoma often affects young adults and is characterized by …

Simple Summary The aim of this review is to provide an overview of the biological basis of
pathogenesis and current research in extraskeletal myxoid chondrosarcoma (EMC) …

Osteosarcoma is a rare bone tumor that occurs in young adults with a subsequent peak in
the fifth decade. Neoadjuvant and adjuvant chemotherapy and surgery cure approximately …

Sarcomas are mesenchymal tumors, encompassing more than 175 subtypes, each one with
their own genetic complexities. As a result, immunotherapy approaches have not been …

Soft-tissue sarcomas constitute an uncommon and heterogeneous group of tumors of
mesenchymal origin. Diagnosis, treatment, and management should be performed by an …

Simple Summary The systemic treatment of advanced sarcoma remains challenging.
Conventional chemotherapy and anti-angiogenic agents, even in the most responsive …

Sarcomas are a heterogeneous group of malignancies of mesenchymal origin; their
molecular and genomic mechanisms differ with regard to histology. These characteristics …

Soft-tissue sarcomas (STS) are a rare and heterogeneous group of malignant tumors that
arise from the oncogenic transformation of mesenchymal tissue. There are over 100 distinct …